Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>S=ТИРАПАЗАМИН<.>)
Общее количество найденных документов : 38
Показаны документы с 1 по 20
 1-20    21-38 
1.
A mass spectrometry study of tirapazamine and its metabolites: Insights into the mechanism of metabolic transformations and the characterization of reaction intermediates // J. Amer. Soc. Mass Spectrom., 2003. Vol. 14, N 8.-С.881-892

2.
Adaptation of human tumor cells to tirapazamine under aerobic conditions. Implications of increased antioxidant enzyme activity to mechanism of aerobic cytotoxicity // Biochem. Pharmacol., 1997. Vol. 54, N 2.-С.249-257

3.
Adaptation of human tumor cells to tirapazamine under aerobic conditions. Implications of increased antioxidant enzyme activity to mechanism of aerobic cytotoxicity // Biochem. Pharmacol., 1997. Vol. 54, N 2.-С.249-257

4.
Combined treatment with continuos administration of tirapazamine and mild temperature hyperthermia in 'гамма'-ray irradiation in terms of local tumor response and lung metastatic potential // KURRI Progr. Rept, 2013.-С.148

5.
Combined treatment with continuos administration of tirapazamine and mild temperature hyperthermia in 'гамма'-ray irradiation in terms of local tumor response and lung metastatic potential // KURRI Progr. Rept, 2013.-С.148

6.
Combined treatment with continuos administration of tirapazamine and mild temperature hyperthermia in 'гамма'-ray irradiation in terms of local tumor response and lung metastatic potential // KURRI Progr. Rept, 2013.-С.148

7.
Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation // Radiat. Oncol. Invest., 1999. Vol. 7, N 3.-С.163-169

8.
Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation // Radiat. Oncol. Invest., 1999. Vol. 7, N 3.-С.163-169

9.
Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation // Radiat. Oncol. Invest., 1999. Vol. 7, N 3.-С.163-169

10.
Direct evidence for bimodal DNA damage induced by tirapazamine // Chem. Res. Toxicol., 1998. Vol. 11, N 11.-С.1254-1257

11.
Direct evidence for bimodal DNA damage induced by tirapazamine // Chem. Res. Toxicol., 1998. Vol. 11, N 11.-С.1254-1257

12.
Effect of interstitial and/or systemic delivery of tirapazamine on the radiosensitivity of human glioblastoma multiforme in nude mice // Radiat. Oncol. Invest., 1998. Vol. 6, N 2.-С.63-70

13.
Effect of interstitial and/or systemic delivery of tirapazamine on the radiosensitivity of human glioblastoma multiforme in nude mice // Radiat. Oncol. Invest., 1998. Vol. 6, N 2.-С.63-70

14.
Effect of interstitial and/or systemic delivery of tirapazamine on the radiosensitivity of human glioblastoma multiforme in nude mice // Radiat. Oncol. Invest., 1998. Vol. 6, N 2.-С.63-70

15.
Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy // In vivo, 2010. Vol. 24, N 1.-С.1-8

16.
Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy // In vivo, 2010. Vol. 24, N 1.-С.1-8

17.
Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy // In vivo, 2010. Vol. 24, N 1.-С.1-8

18.
Patterson L.H. Electron paramagnetic resonance spectrometry evidence for bioreduction of tirapazamine to oxidizing free-radicals under anaerobic conditions // Biochem. Pharmacol., 2000. Vol. 60, N 12.-С.1933-1935

19.
Hypoxia-targeting agent in phase III lung Ca // Oncol. News Int., 2002. Vol. 11, N 1.-С.35

20.
Hypoxia-targeting agent in phase III lung Ca // Oncol. News Int., 2002. Vol. 11, N 1.-С.35

 1-20    21-38 
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)